Breaking News

Mabion Launches €500,000 Oncology Services Contest

An independent jury of experts will evaluate entries based on scientific merit, feasibility, and potential patient impact.

By: Rachel Klemovitch

Assistant Editor

Mabion, a biotech-focused CDMO offering end-to-end services, has launched a €500,000 oncology services contest at BIO International Convention 2025. This initiative hopes to accelerate the development of recombinant protein-based cancer therapies.  The contest will culminate at CPHI Worldwide in Frankfurt this October, spotlighting promising biotech’s ready to scale their innovation. The initiative provides a simplified entry process via QR code at Mabion’s booth and a dedicated landing pa...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters